Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation
Stopped Study was terminated prior to enrolling protocol target accrual goal due to declining accrual and Data Safety Monitoring Board recommendations.
Conditions
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Aggressive Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Diffuse Large B-Cell Lymphoma
- Mantle Cell Lymphoma
- Myelodysplastic Syndrome
- Myelodysplastic/Myeloproliferative Neoplasm
- Prolymphocytic Leukemia
- Recurrent Chronic Lymphocytic Leukemia
- Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Recurrent Hodgkin Lymphoma
- Recurrent Plasma Cell Myeloma
- Recurrent Small Lymphocytic Lymphoma
- Recurrent Waldenstrom Macroglobulinemia
- Hematologic and Lymphocytic Disorder
- Blastic Plasmacytoid Dendritic Cell Neoplasm
Interventions
- PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
- DRUG: Cyclophosphamide
- DRUG: Cyclosporine
- DRUG: Mycophenolate Mofetil
- DRUG: Sirolimus
Sponsor
Fred Hutchinson Cancer Center
Collaborators
- [object Object]
- [object Object]